L1CAM and neoplasm: When we correlated the expression of L1CAM in EC with DFS, we found that higher expression of L1CAM was present in tumor patients with lower disease free survival (5y-DFS 26.1% vs 60.7%, p = 0.002) (Fig. 2a).